Champions Oncology (CSBR) Invested Capital (2016 - 2025)
Historic Invested Capital for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $4.2 million.
- Champions Oncology's Invested Capital rose 52129.22% to $4.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.2 million, marking a year-over-year increase of 52129.22%. This contributed to the annual value of $3.8 million for FY2025, which is 29821.33% up from last year.
- Champions Oncology's Invested Capital amounted to $4.2 million in Q4 2025, which was up 52129.22% from $3.5 million recorded in Q3 2025.
- Champions Oncology's Invested Capital's 5-year high stood at $9.2 million during Q1 2022, with a 5-year trough of -$2.1 million in Q1 2024.
- For the 5-year period, Champions Oncology's Invested Capital averaged around $4.7 million, with its median value being $5.1 million (2023).
- In the last 5 years, Champions Oncology's Invested Capital crashed by 14104.83% in 2024 and then soared by 116566.27% in 2025.
- Over the past 5 years, Champions Oncology's Invested Capital (Quarter) stood at $8.1 million in 2021, then increased by 13.64% to $9.2 million in 2022, then tumbled by 98.99% to $93000.0 in 2023, then soared by 632.26% to $681000.0 in 2024, then surged by 521.29% to $4.2 million in 2025.
- Its Invested Capital stands at $4.2 million for Q4 2025, versus $3.5 million for Q3 2025 and $3.8 million for Q2 2025.